Summary Basis of Decision for Tryngolza​Health Canada RSS – Drug Products, Drugs and Health Products

 Health Canada Summary Basis of Decision 2026-04-13. Tryngolza, 80 mg/0.8 mL olezarsen, solution, Theratechnologies Inc. Submission Control Number 297894

Leave a Reply